Matthew Davis

Company: Gritstone Bio

Job title: Director, Molecular Biology & Sequencing

Seminars:

Redefining Surrogate Endpoints for Enhanced Efficacy in Novel Immunotherapies 2:40 pm

Building cell-free DNA (cfDNA) for tumor informed and tumor naive panel to monitor tumor mutational burden (TMB) Identifying biochemical molecular responses and translating them using biopsy sequencing and ex vivo immunology assays Identifying mechanisms of action to drive individual translational assays built for personalized medicineRead more

day: Day 1 Track B PM